Propyl perfluoropentanoate

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 卤代烷
• 英文名称: Propyl perfluoropentanoate
• 英文别名: propyl 2,2,3,3,4,4,5,5,5-nonafluoropentanoate
• 化学式: C₈H₇F₉O₂
• 分子量: 306.13
• InChiKey: CQTLZOHQVZFPOE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  11

文献信息

• FLUORINE-CONTAINING COPOLYMER COMPOSITION AND METHOD FOR PRODUCING SAME
  申请人：Asahi Glass Company, Limited

  公开号：EP2450406B1

  公开（公告）日：2015-10-14
• FLUOROCOPOLYMER COMPOSITION AND ITS PRODUCTION PROCESS
  申请人：NAKANO Takashi

  公开号：US20120108723A1

  公开（公告）日：2012-05-03

  To provide a composition comprising a fluorocopolymer such as an ETFE which can be produced at a relatively low temperature, and its production process. A fluorocopolymer composition which comprises a fluorocopolymer such as an ETFE and a C 6-10 aliphatic compound having one carbonyl group, and which is in a solution state being at a temperature of at most the melting point of the fluorocopolymer, and a process for producing the fluorocopolymer composition, which comprises a step of dissolving the fluorocopolymer in the aliphatic compound having one carbonyl group at a temperature of at most the melting point of the fluorocopolymer.
• PERFLUORINATED COMPOUNDS FOR THE NON-VIRAL TRANSFER OF NUCLEIC ACIDS
  申请人：Schäfer Konstanze

  公开号：US20140065223A1

  公开（公告）日：2014-03-06

  The invention relates to a compound of general formula (I): A-B-C(F, G′)-D-E-F-G-A′ or a structure of general formula (II): A-B-C-(F′, G′)-D-B-E-F-G-A′ (II), wherein -A is at least one molecule selected from the group of the perfluorocarbons (PFCs), perfluorinated silicon compounds, and/or further perfluorinated compounds, -B is at least one predetermined breaking point in the form of a physically, chemically, or enzymatically severable bond, -C is absent or at least one linker molecule, -D is absent or at least one spacer molecule, -E is at least one molecule selected from the group containing nucleobases, nucleosides, nucleotides, oligonucleotides, nucleic, acids, modified nucleobases, modified nucleosides, modified nucleotides, modified oligonucleotides, modified nucleic acids, monomers of peptide nucleic acids, oligomers or peptide nucleic acids and peptide nucleic acids or other nucleic acid analogs, -F, F′ is absent or at least one ligand, -G, G′ is absent or at least one marker molecule, -A′ is absent or has the meaning of A, and wherein the compounds i), ii), iii), iv), v), vi) are excluded. The invention farther relates to the use of said compound for the non-viral transfer of molecule E into a cell, to a pharmaceutical composition containing said compound, and to the use of said pharmaceutical composition.
• INERTIZATION OF MATERIAL SURFACES BY FUNCTIONALIZED PERFLUORINATED MOLECULES
  申请人：Technische Universität Berlin

  公开号：US20220176405A1

  公开（公告）日：2022-06-09

  A method for rendering material surfaces inert is provided. Exemplary surfaces include ceramic, metal or plastic surfaces. The method is accomplished with functionalized perfluorinated compounds for the formation of hyperhydrophobic structures on the surfaces to create inert surfaces. The inert surfaces produced or can be produced in this way have an extremely low surface energy, are resistant to deposits of substances or cells and have a very low coefficient of friction. Practical uses of the inert surfaces are also provided.
• [DE] PERFLUORIERTE VERBINDUNGEN ZUM NICHT-VIRALEN TRANSFER VON NUKLEINSÄUREN<br/>[EN] PERFLUORINATED COMPOUNDS FOR THE NON-VIRAL TRANSFER OF NUCLEIC ACIDS<br/>[FR] COMPOSÉS PERFLUORÉS POUR LE TRANSFERT NON VIRAL D'ACIDES NUCLÉIQUES
  申请人：SCHAEFER KONSTANZE

  公开号：WO2012130941A2

  公开（公告）日：2012-10-04

  Die vorliegende Erfindung betrifft eine Verbindung der allgemeinen Formel (I): A - B - C(F, G')- D- E - F - G-A' oder eine Struktur der allgemeinen Formel (II): A - B - C(F', G')- D - B - E - F - G - A' (II), wobei - A mindestes ein Molekül ausgewählt aus der Gruppe der Perfluorocarbone (PFC), Perfluorsiliziumverbindungen und/oder weiterer perfluorierter Verbindungen ist, - B mindestens eine Sollbruchstelle in Form einer physikalisch, chemisch oder enzymatisch trennbaren Bindung ist, - C abwesend oder mindestens ein Linkermolekül ist, - D abwesend oder mindestens ein Spacermolekül ist, - E mindestens ein Molekül ausgewählt aus der Gruppe enthaltend Nukleobasen, Nukleoside, Nukleotide, Oligonukleotide, Nukleinsäuren, modifizierte Nukleobasen, modifizierte Nukleoside, modifizierte Nukleotide, modifizierte Oligonukleotide, modifizierte Nukleinsäuren, Monomere von Peptid-Nukleinsäuren, Oligomere von Peptid-Nukleinsäuren und Peptid-Nukleinsäuren oder anderen Nukleinsäure-Analogen ist, - F, F' abwesend oder mindestens ein Ligand ist, - G, G' abwesend oder mindestens ein Markermolekül ist, - A' abwesend oder die Bedeutung von A, und wobei die Verbindungen i), ii), iii), iv), v), vi) ausgenommen sind. Die vorliegende Verbindung betrifft ebenfalls die Verwendung diese Verbindung zum nicht-viralen Transfer des Moleküls E in eine Zelle, eine pharmazeutische Zusammensetzung enthaltend diese Verbindung und deren Verwendung.